Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy
Derrick McCarthy, Jonathan Woon-Teck Yap, Christopher Harp, et al.
Nanomedicine Nanotechnology Biology and Medicine (2016) Vol. 13, Iss. 1, pp. 191-200
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study
Ciarán P. Kelly, Joseph A. Murray, Daniel A. Leffler, et al.
Gastroenterology (2021) Vol. 161, Iss. 1, pp. 66-80.e8
Open Access | Times Cited: 134
Therapeutic induction of antigen-specific immune tolerance
Jessica E. Kenison, Nikolas A. Stevens, Francisco J. Quintana
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 338-357
Open Access | Times Cited: 45
Cell migration: implications for repair and regeneration in joint disease
Feini Qu, Farshid Guilak, Robert L. Mauck
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 3, pp. 167-179
Open Access | Times Cited: 144
Nanoparticles for the Induction of Antigen-Specific Immunological Tolerance
Takashi Kishimoto, Roberto Maldonado
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 143
Modulating the immune system through nanotechnology
Tamara G. Dacoba, Olivera Ana, Dolores Torres, et al.
Seminars in Immunology (2017) Vol. 34, pp. 78-102
Open Access | Times Cited: 125
Gliadin Nanoparticles Induce Immune Tolerance to Gliadin in Mouse Models of Celiac Disease
Tobias Freitag, Joseph R. Podojil, Ryan M. Pearson, et al.
Gastroenterology (2020) Vol. 158, Iss. 6, pp. 1667-1681.e12
Open Access | Times Cited: 116
In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance
Ryan M. Pearson, Liam M. Casey, Kevin R. Hughes, et al.
Advanced Drug Delivery Reviews (2017) Vol. 114, pp. 240-255
Open Access | Times Cited: 103
Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells
Suchitra Prasad, Tobias Neef, Dan Xu, et al.
Journal of Autoimmunity (2017) Vol. 89, pp. 112-124
Open Access | Times Cited: 92
Evaluating and Mitigating the Immunogenicity of Therapeutic Proteins
Zuben E. Sauna, Daniel Lagassé, João Pedras-Vasconcelos, et al.
Trends in biotechnology (2018) Vol. 36, Iss. 10, pp. 1068-1084
Closed Access | Times Cited: 92
Controlled Delivery of Single or Multiple Antigens in Tolerogenic Nanoparticles Using Peptide-Polymer Bioconjugates
Ryan M. Pearson, Liam M. Casey, Kevin R. Hughes, et al.
Molecular Therapy (2017) Vol. 25, Iss. 7, pp. 1655-1664
Open Access | Times Cited: 89
Targeted immunomodulation of inflammatory monocytes across the blood-brain barrier by curcumin-loaded nanoparticles delays the progression of experimental autoimmune encephalomyelitis
Lisen Lu, Shuhong Qi, Yuzhou Chen, et al.
Biomaterials (2020) Vol. 245, pp. 119987-119987
Closed Access | Times Cited: 86
Designing drug-free biodegradable nanoparticles to modulate inflammatory monocytes and neutrophils for ameliorating inflammation
Eiji Saito, Robert Kuo, Ryan M. Pearson, et al.
Journal of Controlled Release (2019) Vol. 300, pp. 185-196
Open Access | Times Cited: 84
Therapeutic proteins: developments, progress, challenges, and future perspectives
Vimal Kumar, Arti Barwal, Nitin Sharma, et al.
3 Biotech (2024) Vol. 14, Iss. 4
Closed Access | Times Cited: 11
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
Yi Song, Jian Li, Yuzhang Wu
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Emerging strategies for nanomedicine in autoimmunity
Ajay S. Thatte, Margaret M. Billingsley, Drew Weissman, et al.
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115194-115194
Closed Access | Times Cited: 8
Engineered immunological niche directs therapeutic development in models of progressive multiple sclerosis
Laila M. Rad, Kevin R. Hughes, Sydney N. Wheeler, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 7
Open Access | Times Cited: 1
Antigen-specific immunotherapies in rheumatic diseases
Judit Pozsgay, Zoltán Szekanecz, Gabriella Sármay
Nature Reviews Rheumatology (2017) Vol. 13, Iss. 9, pp. 525-537
Closed Access | Times Cited: 80
Conjugation of Transforming Growth Factor Beta to Antigen-Loaded Poly(lactide-co-glycolide) Nanoparticles Enhances Efficiency of Antigen-Specific Tolerance
Liam M. Casey, Ryan M. Pearson, Kevin R. Hughes, et al.
Bioconjugate Chemistry (2017) Vol. 29, Iss. 3, pp. 813-823
Open Access | Times Cited: 74
Overcoming challenges in treating autoimmuntity: Development of tolerogenic immune-modifying nanoparticles
Ryan M. Pearson, Joseph R. Podojil, Lonnie D. Shea, et al.
Nanomedicine Nanotechnology Biology and Medicine (2018) Vol. 18, pp. 282-291
Open Access | Times Cited: 73
An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis
Jonathan Cho, Joshua M. Stewart, Theodore T. Drashansky, et al.
Biomaterials (2017) Vol. 143, pp. 79-92
Open Access | Times Cited: 72
Nanomodulation of Macrophages in Multiple Sclerosis
Frances K. Nally, Chiara De Santi, Claire E. McCoy
Cells (2019) Vol. 8, Iss. 6, pp. 543-543
Open Access | Times Cited: 69
Cargo-less nanoparticles program innate immune cell responses to toll-like receptor activation
Liam M. Casey, Sandeep Kakade, Joseph T. Decker, et al.
Biomaterials (2019) Vol. 218, pp. 119333-119333
Open Access | Times Cited: 67
Nanoscale delivery systems for cancer immunotherapy
Zejun Wang, Wenhan Liu, Jiye Shi, et al.
Materials Horizons (2018) Vol. 5, Iss. 3, pp. 344-362
Closed Access | Times Cited: 63
Design of biodegradable nanoparticles to modulate phenotypes of antigen-presenting cells for antigen-specific treatment of autoimmune disease
Eiji Saito, Robert Kuo, Kevin R. Kramer, et al.
Biomaterials (2019) Vol. 222, pp. 119432-119432
Open Access | Times Cited: 58
Pre-clinical and Clinical Implications of “Inside-Out” vs. “Outside-In” Paradigms in Multiple Sclerosis Etiopathogenesis
Haley E. Titus, Yanan Chen, Joseph R. Podojil, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top